The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.
Vaccines (Basel)
; 11(3)2023 Mar 17.
Article
em En
| MEDLINE
| ID: mdl-36992275
COVAX; COVID-19 vaccine lessons; R&D blueprints; controlling transmission; disease X and pathogen X; epidemic and pandemic prevention; low- and middle-income country (LMIC) vaccine innovation and manufacture; mRNA); modular vaccine production; mucosal immunity; pan-coronavirus vaccines; platform technologies (esp. inactivated viruses; public investments and subsidies; recombinant proteins; regulatory challenges; technology global commons and global public goods; vaccine access; vaccine business model and value proposition; vaccine intellectual property (IP) and know-how transfer; vaccine prototypes; variants and booster strategies; viral vectors
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Contexto em Saúde:
1_ASSA2030
Problema de saúde:
1_geracao_evidencia_conhecimento
/
1_medicamentos_vacinas_tecnologias
Tipo de estudo:
Clinical_trials
/
Qualitative_research
Idioma:
En
Revista:
Vaccines (Basel)
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Reino Unido